198 related articles for article (PubMed ID: 1338083)
1. Regression of left ventricular hypertrophy in previously untreated essential hypertension: different effects of enalapril and hydrochlorothiazide.
Dahlöf B; Hansson L
J Hypertens; 1992 Dec; 10(12):1513-24. PubMed ID: 1338083
[TBL] [Abstract][Full Text] [Related]
2. Structural cardiovascular changes in essential hypertension. Studies on the effect of antihypertensive therapy.
Dahlöf B
Blood Press Suppl; 1992; 6():1-75. PubMed ID: 1345261
[TBL] [Abstract][Full Text] [Related]
3. Long-term effects of losartan and enalapril, alone or with a diuretic, on ambulatory blood pressure and cardiac performance in hypertension: a case-control study.
Verdecchia P; Schillaci G; Reboldi GP; Sacchi N; Bruni B; Benemio G; Porcellati C
Blood Press Monit; 2000 Jun; 5(3):187-93. PubMed ID: 10915233
[TBL] [Abstract][Full Text] [Related]
4. The influence of antihypertensive therapy on the structural arteriolar changes in essential hypertension: different effects of enalapril and hydrochlorothiazide.
Dahlöf B; Hansson L
J Intern Med; 1993 Sep; 234(3):271-9. PubMed ID: 8354977
[TBL] [Abstract][Full Text] [Related]
5. Effects of eplerenone, enalapril, and eplerenone/enalapril in patients with essential hypertension and left ventricular hypertrophy: the 4E-left ventricular hypertrophy study.
Pitt B; Reichek N; Willenbrock R; Zannad F; Phillips RA; Roniker B; Kleiman J; Krause S; Burns D; Williams GH
Circulation; 2003 Oct; 108(15):1831-8. PubMed ID: 14517164
[TBL] [Abstract][Full Text] [Related]
6. ACE inhibition with spirapril improves diastolic function at rest independent of vasodilation during treatment with spirapril in mild to moderate hypertension.
Petersen JR; Drabaek H; Gleerup G; Mehlsen J; Petersen LJ; Winther K
Angiology; 1996 Mar; 47(3):233-40. PubMed ID: 8638865
[TBL] [Abstract][Full Text] [Related]
7. Effects of once-daily angiotensin-converting enzyme inhibition and calcium channel blockade-based antihypertensive treatment regimens on left ventricular hypertrophy and diastolic filling in hypertension: the prospective randomized enalapril study evaluating regression of ventricular enlargement (preserve) trial.
Devereux RB; Palmieri V; Sharpe N; De Quattro V; Bella JN; de Simone G; Walker JF; Hahn RT; Dahlöf B
Circulation; 2001 Sep; 104(11):1248-54. PubMed ID: 11551875
[TBL] [Abstract][Full Text] [Related]
8. Reduction of left ventricular mass by short-term antihypertensive treatment with isradipine: a double-blind comparison with enalapril.
Galderisi M; Celentano A; Garofalo M; Tammaro P; Oliviero M; Petrocelli A; de Divitiis O
Int J Clin Pharmacol Ther; 1994 Jun; 32(6):312-6. PubMed ID: 7921533
[TBL] [Abstract][Full Text] [Related]
9. Left ventricular systolic function after marked reduction of ventricular hypertrophy induced by 5 years' enalapril treatment.
González-Juanatey JR; Pose Reino A; García Acuña JM; Castelo Fuentes V; Amaro Gendón A; Calvo Gómez C; Gil de la Peña M
Eur Heart J; 1995 Dec; 16(12):1981-7. PubMed ID: 8682036
[TBL] [Abstract][Full Text] [Related]
10. ACE inhibitors captopril and enalapril induce regression of left ventricular hypertrophy in hypertensive patients with chronic renal failure.
Dyadyk AI; Bagriy AE; Lebed IA; Yarovaya NF; Schukina EV; Taradin GG
Nephrol Dial Transplant; 1997 May; 12(5):945-51. PubMed ID: 9175047
[TBL] [Abstract][Full Text] [Related]
11. Effects of enalapril and isradipine alone and in combination on blood pressure, renal function and echocardiographic parameters in mild hypertension.
De Rosa ML; Maddaluno G; Lionetti F; Di Palma U; Albanese L; Cardace P; Baiano A; Vigorito C
Int J Cardiol; 2000 Jun; 74(1):77-84. PubMed ID: 10854683
[TBL] [Abstract][Full Text] [Related]
12. Effects of nitrendipine and enalapril on left ventricular mass in patients with non-insulin-dependent diabetes mellitus and hypertension.
Gerritsen TA; Bak AA; Stolk RP; Jonker JJ; Grobbee DE
J Hypertens; 1998 May; 16(5):689-96. PubMed ID: 9797181
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of different drug classes used to initiate antihypertensive treatment in black subjects: results of a randomized trial in Johannesburg, South Africa.
Sareli P; Radevski IV; Valtchanova ZP; Libhaber E; Candy GP; Den Hond E; Libhaber C; Skudicky D; Wang JG; Staessen JA
Arch Intern Med; 2001 Apr; 161(7):965-71. PubMed ID: 11295959
[TBL] [Abstract][Full Text] [Related]
14. Physical performance is preserved after regression of left ventricular hypertrophy.
Lacourcière Y; Poirier L; Cléroux J
J Cardiovasc Pharmacol; 1997 Sep; 30(3):383-91. PubMed ID: 9300324
[TBL] [Abstract][Full Text] [Related]
15. Comparison of lercanidipine plus hydrochlorothiazide vs. lercanidipine plus enalapril on micro and macrocirculation in patients with mild essential hypertension.
De Ciuceis C; Salvetti M; Paini A; Rossini C; Muiesan ML; Duse S; Caletti S; Coschignano MA; Semeraro F; Trapletti V; Bertacchini F; Brami V; Petelca A; Agabiti Rosei E; Rizzoni D; Agabiti Rosei C
Intern Emerg Med; 2017 Oct; 12(7):963-974. PubMed ID: 28647890
[TBL] [Abstract][Full Text] [Related]
16. Left ventricular changes after chronic therapy with enalapril maleate in moderate to severe hypertensive patients.
Fernandez PG; Kim BK; Snedden W; Nolan R; Ko P
Curr Med Res Opin; 1984; 9(3):170-83. PubMed ID: 6094104
[TBL] [Abstract][Full Text] [Related]
17. Effects of losartan titrated to Losartan/Hydrochlorothiazide and amlodipine on left ventricular mass in patients with mild-to-moderate hypertension. A double-blind randomized controlled study.
Martina B; Dieterle T; Weinbacher M; Battegay E
Cardiology; 1999; 92(2):110-4. PubMed ID: 10702653
[TBL] [Abstract][Full Text] [Related]
18. Angiotensin converting enzyme inhibition and dihydropyridine calcium channel blockade in the treatment of left ventricular hypertrophy in arterial hypertension.
Palmieri V; Devereux RB
Minerva Cardioangiol; 2002 Jun; 50(3):169-74. PubMed ID: 12107398
[TBL] [Abstract][Full Text] [Related]
19. Preserved ventricular pump function after a marked reduction of left ventricular mass.
Ketelhut R; Franz IW; Behr U; Toennesmann U; Messerli FH
J Am Coll Cardiol; 1992 Oct; 20(4):864-8. PubMed ID: 1356116
[TBL] [Abstract][Full Text] [Related]
20. Beta-blockers vs. angiotensin-converting enzyme inhibitors in hypertension: effects on left ventricular hypertrophy.
Gosse P; Roudaut R; Herrero G; Dallocchio M
J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S145-50. PubMed ID: 11527119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
